
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $173.2M | -- | -- | -$0.31 | -- |
08/01/2025 | Q2 | $173.9M | -- | -- | -$0.47 | -- |
05/01/2025 | Q1 | $153.4M | $158.7M | -$0.97 | -$0.94 | -$0.03 |
02/20/2025 | Q4 | $158.3M | $164.3M | -$0.04 | -$0.24 | $0.20 |
10/30/2024 | Q3 | $146.7M | $147.5M | -$1.48 | -$0.57 | -$0.91 |
08/01/2024 | Q2 | $146.2M | $148M | -$0.65 | -$0.88 | $0.23 |
05/02/2024 | Q1 | $128.4M | $131.9M | -$1.47 | -$0.99 | -$0.48 |
02/22/2024 | Q4 | $130.2M | $132.5M | -$1.26 | -$0.61 | -$0.65 |
11/02/2023 | Q3 | -- | -- | -$0.89 | -$0.58 | -$0.31 |
08/03/2023 | Q2 | -- | -- | -$0.61 | -$0.75 | $0.14 |
05/04/2023 | Q1 | -- | -- | -$1.29 | -$0.86 | -$0.43 |
02/23/2023 | Q4 | -- | -- | -$0.67 | -$0.61 | -$0.06 |
11/01/2022 | Q3 | -- | -- | -$0.71 | -$0.81 | $0.10 |
08/04/2022 | Q2 | -- | -- | -$0.80 | -$0.90 | $0.10 |
05/05/2022 | Q1 | -- | -- | -$1.71 | -$1.06 | -$0.65 |
02/23/2022 | Q4 | -- | -- | -$1.10 | -$1.13 | $0.03 |
11/04/2021 | Q3 | -- | -- | -$0.81 | -$1.07 | $0.26 |
08/05/2021 | Q2 | -- | -- | -$0.59 | -$0.94 | $0.35 |
05/06/2021 | Q1 | -- | -- | -$0.95 | -$0.85 | -$0.10 |
02/25/2021 | Q4 | -- | -- | -$0.33 | -$0.33 | -$0.00 |
11/05/2020 | Q3 | -- | -- | -$0.17 | -$0.52 | $0.35 |
08/06/2020 | Q2 | -- | -- | -$0.75 | -$0.75 | $0.00 |
05/07/2020 | Q1 | -- | -- | -$0.34 | -$0.56 | $0.22 |
02/27/2020 | Q4 | -- | -- | -$0.65 | -$0.50 | -$0.15 |
11/05/2019 | Q3 | -- | -- | -$0.72 | -$0.40 | -$0.33 |
07/31/2019 | Q2 | -- | -- | -$0.43 | -$0.44 | $0.01 |
05/07/2019 | Q1 | -- | -- | -$0.34 | -$0.48 | $0.14 |
02/12/2019 | Q4 | -- | -- | -$0.61 | -$0.45 | -$0.16 |
10/31/2018 | Q3 | -- | -- | -$0.40 | -- | -- |
08/01/2018 | Q2 | -- | -- | -$0.51 | -- | -- |
05/02/2018 | Q1 | -- | -- | -$0.47 | -- | -- |
02/14/2018 | Q4 | -- | -- | -$0.48 | -- | -- |
11/01/2017 | Q3 | -- | -- | -$0.29 | -- | -- |
08/02/2017 | Q2 | -- | -- | -$0.29 | -- | -- |
03/31/2017 | Q1 | -- | -- | -$0.24 | -- | -- |
02/15/2017 | Q4 | -- | -- | -$0.37 | -- | -- |
12/05/2016 | Q3 | -- | -- | -$0.20 | -- | -- |
06/30/2016 | Q2 | -- | -- | -$0.22 | -- | -- |
03/31/2016 | Q1 | -- | -- | -$0.41 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$0.52 | -- | -- |
09/30/2015 | Q3 | -- | -- | -$0.39 | -- | -- |
iRhythm Technologies reported $158.7M worth of top line sales in its most recent quarter.
iRhythm Technologies announced earnings per share of -$0.97 which represents a miss of analyst forecast a -$0.94 per share.
iRhythm Technologies reported $109.2M that represents $3.46 per share over the last quarter.
iRhythm Technologies's earnings are forecast to decrease from -$3.63 per share to -$3.09 per share next year representing a decrease of -52.82%.
iRhythm Technologies's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.